Professor | 曹德东 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	曹德东
Contact Information	caodedong123@whu.edu.cn
Language ability	英语, 汉语
Province	湖北省

Upload Avatar (500 x 500)

Name

曹德东

Contact Information

caodedong123@whu.edu.cn

Language ability

英语, 汉语

Province

湖北省

University/Lab Affiliation and Title	武汉大学
Faculty	Medical School
Academic Background & Achievements	2004.09-2009.06 郧阳医学院第二临床学院临床医学专业本科生获学士学位 2009.09-2011.06 武汉大学第一临床学院肿瘤学硕士研究生获硕士学位 2011.09-2014.06 华中科技大学同济医学院第一临床学院内科学博士研究生获博士学位
Work Experience	2014.07-2014.10 武汉大学人民医院肿瘤三科医师 2014.11-2017.10 武汉大学人民医院肿瘤三科主治医师 2017.11-2018.01 武汉大学人民医院肿瘤三科副主任医师 2018.02-2019.07 美国 Fred Hutchinson Cancer Research Center访问学者 2019.08-2020.01 武汉大学人民医院肿瘤三科副主任医师 2020.02-2020.04 武汉大学人民医院发热门诊、发热留观病房副主任医师 2020.05-2022.11 武汉大学人民医院肿瘤三科副主任医师 2022.04至今武汉大学人民医院医疗部副部长 2022.11至今武汉大学人民医院肿瘤三科主任医师，副教授
Awards	原发性肝癌发生发展的机制及其精准治疗，湖北省科学技术进步一等奖重组人血管内皮抑素（Endostar）增加放疗敏感性的机制及临床应用探讨，湖北省科学技术进步三等奖重组人血管内皮抑素（Endostar）增加放疗敏感性的机制及临床应用探讨，武汉市科学技术进步三等奖

University/Lab Affiliation and Title

武汉大学

Faculty

Medical School

Academic Background & Achievements

2004.09-2009.06 郧阳医学院第二临床学院临床医学专业本科生获学士学位
2009.09-2011.06 武汉大学第一临床学院肿瘤学硕士研究生获硕士学位
2011.09-2014.06 华中科技大学同济医学院第一临床学院内科学博士研究生获博士学位

Work Experience

2014.07-2014.10 武汉大学人民医院肿瘤三科医师
2014.11-2017.10 武汉大学人民医院肿瘤三科主治医师
2017.11-2018.01 武汉大学人民医院肿瘤三科副主任医师
2018.02-2019.07 美国 Fred Hutchinson Cancer Research Center访问学者
2019.08-2020.01 武汉大学人民医院肿瘤三科副主任医师
2020.02-2020.04 武汉大学人民医院发热门诊、发热留观病房副主任医师
2020.05-2022.11 武汉大学人民医院肿瘤三科副主任医师
2022.04至今武汉大学人民医院医疗部副部长
2022.11至今武汉大学人民医院肿瘤三科主任医师，副教授

Awards

原发性肝癌发生发展的机制及其精准治疗，湖北省科学技术进步一等奖
重组人血管内皮抑素（Endostar）增加放疗敏感性的机制及临床应用探讨，湖北省科学技术进步三等奖
重组人血管内皮抑素（Endostar）增加放疗敏感性的机制及临床应用探讨，武汉市科学技术进步三等奖

Areas of Focus	放射治疗增敏策略与机制肿瘤代谢与免疫治疗肿瘤循证医学
Publications	The application of nanoparticles in immunotherapy for hepatocellular carcinoma, Hu X, Zhu H, He X, Chen J, Xiong L, Shen Y, Li J, Xu Y, Chen W, Liu X, Cao D, Xu X, 2023 Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers, Shen Y, Zhao N, Zhao N, Hu X, He X, Xu Y, Chen J, Chen W, Liu X, Zhou Z, Cao D, Xu X, 2022 Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients, Feng J, Ren J, Li X, Zhang X, Yang Q, Wu Z, Cui L, Liao L, Gong Y, Cao D, 2022 The association between antibiotics use and outcome of cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis, Xu H, Xu X, Wang H, Ge W, Cao D, 2020 High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients, Cao D, Xu H, Xu X, Guo T, Ge W, 2019 The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis, Xu H, Xu X, Ge W, Lei J, Cao D, 2020 A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies, D Cao, H Xu, X Xu, T Guo, W Ge, 2018 The effects of prophylactic cranial irradiation versus control on survival of patients with extensive-stage small-cell lung cancer: a meta-analysis of 14 trials, W Ge, H Xu, Y Yan, D Cao, 2018 Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis, Xu H, Cao D, Zhou D, He A, Ge W, Xu X, 2023 Bevacizumab improves survival in metastatic colore

Areas of Focus

放射治疗增敏策略与机制
肿瘤代谢与免疫治疗
肿瘤循证医学

Publications

The application of nanoparticles in immunotherapy for hepatocellular carcinoma, Hu X, Zhu H, He X, Chen J, Xiong L, Shen Y, Li J, Xu Y, Chen W, Liu X, Cao D, Xu X, 2023
Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers, Shen Y, Zhao N, Zhao N, Hu X, He X, Xu Y, Chen J, Chen W, Liu X, Zhou Z, Cao D, Xu X, 2022
Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients, Feng J, Ren J, Li X, Zhang X, Yang Q, Wu Z, Cui L, Liao L, Gong Y, Cao D, 2022
The association between antibiotics use and outcome of cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis, Xu H, Xu X, Wang H, Ge W, Cao D, 2020
High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients, Cao D, Xu H, Xu X, Guo T, Ge W, 2019
The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis, Xu H, Xu X, Ge W, Lei J, Cao D, 2020
A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies, D Cao, H Xu, X Xu, T Guo, W Ge, 2018
The effects of prophylactic cranial irradiation versus control on survival of patients with extensive-stage small-cell lung cancer: a meta-analysis of 14 trials, W Ge, H Xu, Y Yan, D Cao, 2018
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis, Xu H, Cao D, Zhou D, He A, Ge W, Xu X, 2023
Bevacizumab improves survival in metastatic colore

放疗增敏机制肿瘤代谢免疫治疗循证医学肿瘤学临床试验

任斌 - 武汉大学

Area of Focus
脊柱 | 骨骼 | 肿瘤 | 肿瘤学 | 手术 | 治疗 | 研究 | 临床试验 | 医疗保健 | 医学

黄勇 - 武汉大学

徐兵河 - 武汉大学

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们